Critical Functions of the Lysosome in Cancer Biology.

Lysosomes (or lytic bodies) were so named because they contain high levels of hydrolytic enzymes. Lysosome function and dysfunction have been found to play important roles in human disease, including cancer; however, the ways in which lysosomes contribute to tumorigenesis and cancer progression are still being uncovered. Beyond serving as a cellular recycling center, recent evidence suggests that the lysosome is involved in energy homeostasis, generating building blocks for cell growth, mitogenic signaling, priming tissues for angiogenesis and metastasis formation, and activating transcriptional programs. This review examines emerging knowledge of how lysosomal processes contribute to the hallmarks of cancer and highlights vulnerabilities that might be exploited for cancer therapy.

[1]  A. Kariminia,et al.  Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  M. Jäättelä,et al.  Lysosomal involvement in cell death and cancer. , 2009, Biochimica et biophysica acta.

[3]  Yu Zhao,et al.  Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H+‐ATPase Inhibitors , 2015, Chemical biology & drug design.

[4]  Gregory A. Wyant,et al.  The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway , 2016, Cell.

[5]  S. Avnet,et al.  Impairment of Lysosomal Activity as a Therapeutic Modality Targeting Cancer Stem Cells of Embryonal Rhabdomyosarcoma Cell Line RD , 2014, PloS one.

[6]  D. Gottschling,et al.  An Early-Age Increase in Vacuolar pH Limits Mitochondrial Function and Lifespan in Yeast , 2012, Nature.

[7]  R. Abraham,et al.  The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and disease. , 2013, Annual review of pharmacology and toxicology.

[8]  D. Hoepfner,et al.  The Marine Natural Product Manzamine A Targets Vacuolar ATPases and Inhibits Autophagy in Pancreatic Cancer Cells , 2013, Marine drugs.

[9]  M. Serrano,et al.  A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.

[10]  B. Levine,et al.  Autosis and autophagic cell death: the dark side of autophagy , 2014, Cell Death and Differentiation.

[11]  Kailiang Jia,et al.  Autophagy genes function in apoptotic cell corpse clearance during C. elegans embryonic development , 2013, Autophagy.

[12]  Xiaopei Huang,et al.  Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activation. , 2015, The Journal of clinical investigation.

[13]  E. Kassi,et al.  Glucocorticoid receptor signaling and prostate cancer. , 2011, Cancer letters.

[14]  P. Codogno,et al.  Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line , 1997, Cell and Tissue Research.

[15]  R. Halaby Role of lysosomes in cancer therapy , 2015 .

[16]  N. Demartines,et al.  Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives , 2011, Cancers.

[17]  D. Sabatini,et al.  Identification of an oncogenic RAB protein , 2015, Science.

[18]  M. Jäättelä,et al.  Cancer-associated lysosomal changes: friends or foes? , 2013, Oncogene.

[19]  N. Hacohen,et al.  Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. , 2014, Cell reports.

[20]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[21]  C. Thompson,et al.  At the Bench: Preclinical rationale for CTLA‐4 and PD‐1 blockade as cancer immunotherapy , 2013, Journal of leukocyte biology.

[22]  Yang Li,et al.  A nanobuffer reporter library for fine-scale imaging and perturbation of endocytic organelles , 2015, Nature Communications.

[23]  P. Frankel,et al.  Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation , 2014, Cells.

[24]  Gerald C. Chu,et al.  Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. , 2014, Cancer discovery.

[25]  R. Lewensohn,et al.  Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer , 2014, Cell Death and Disease.

[26]  A. Cuervo,et al.  Chaperone-mediated autophagy: roles in disease and aging , 2013, Cell Research.

[27]  Robin Mathew,et al.  Role of autophagy in cancer , 2007, Nature Reviews Cancer.

[28]  Shizuo Akira,et al.  Regulation of innate immune responses by autophagy-related proteins , 2010, The Journal of cell biology.

[29]  W. Schiemann,et al.  Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. , 2004, Molecular cancer research : MCR.

[30]  D. Ruggero,et al.  Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer , 2014, Cell.

[31]  A. Amon,et al.  Short- and long-term effects of chromosome mis-segregation and aneuploidy , 2015, Nature Reviews Molecular Cell Biology.

[32]  K. Ryan,et al.  Loss of autophagy causes a synthetic lethal deficiency in DNA repair , 2015, Proceedings of the National Academy of Sciences.

[33]  K. Taylor,et al.  Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells , 2015, Biochemical Pharmacology.

[34]  T. Walther,et al.  The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.

[35]  U. Brunk,et al.  Lysosomes in iron metabolism, ageing and apoptosis , 2008, Histochemistry and Cell Biology.

[36]  Ira Mellman,et al.  Endocytosis and cancer. , 2013, Cold Spring Harbor perspectives in biology.

[37]  C. Münz Antigen processing via autophagy--not only for MHC class II presentation anymore? , 2010, Current opinion in immunology.

[38]  L. Cantley,et al.  Regulation of mTORC1 by PI3K signaling. , 2015, Trends in cell biology.

[39]  P. Saftig,et al.  Lysosomal membrane proteins: life between acid and neutral conditions. , 2010, Biochemical Society transactions.

[40]  S. Manalis,et al.  Biophysical changes reduce energetic demand in growth factor–deprived lymphocytes , 2016, The Journal of cell biology.

[41]  I. Ellis,et al.  Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer , 2015, Breast Cancer Research and Treatment.

[42]  J. Clohessy,et al.  Pro-senescence therapy for cancer treatment , 2011, Nature Reviews Cancer.

[43]  M. Jäättelä,et al.  Combating apoptosis and multidrug resistant cancers by targeting lysosomes. , 2013, Cancer letters.

[44]  H. Padh,et al.  Organelle targeting: third level of drug targeting , 2013, Drug design, development and therapy.

[45]  J. Goldenring A central role for vesicle trafficking in epithelial neoplasia: intracellular highways to carcinogenesis , 2013, Nature Reviews Cancer.

[46]  S. Terai,et al.  Deferoxamine for advanced hepatocellular carcinoma. , 2011, The New England journal of medicine.

[47]  S. Kornfeld Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. , 1992, Annual review of biochemistry.

[48]  F. López‐Soriano,et al.  Cancer cachexia: understanding the molecular basis , 2014, Nature Reviews Cancer.

[49]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[50]  A. Sorkin,et al.  Endocytosis of receptor tyrosine kinases. , 2013, Cold Spring Harbor perspectives in biology.

[51]  B. Turk,et al.  The endolysosomal system in cell death and survival. , 2013, Cold Spring Harbor perspectives in biology.

[52]  J. Geng,et al.  IGF2R Expression is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC , 2014, Cellular Physiology and Biochemistry.

[53]  P. Gleeson,et al.  Macropinocytosis: an endocytic pathway for internalising large gulps , 2011, Immunology and cell biology.

[54]  Andrea Ballabio,et al.  Signals from the lysosome: a control centre for cellular clearance and energy metabolism , 2013, Nature Reviews Molecular Cell Biology.

[55]  K. Ross,et al.  Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism , 2015, Nature.

[56]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[57]  S. Conzen,et al.  Targeting the glucocorticoid receptor in breast and prostate cancers , 2015, Science Translational Medicine.

[58]  J. Luzio,et al.  Membrane dynamics and the biogenesis of lysosomes (Review) , 2003 .

[59]  E. White,et al.  Role of autophagy in suppression of inflammation and cancer. , 2010, Current opinion in cell biology.

[60]  N. Grishin,et al.  EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.

[61]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[62]  J. Winkler,et al.  Lys05 , 2012, Autophagy.

[63]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[64]  F. Zunino,et al.  SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis , 2011, Clinical Cancer Research.

[65]  M. V. Vander Heiden,et al.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.

[66]  M. Zerial,et al.  Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V , 2012, Molecular biology of the cell.

[67]  H. Hirano,et al.  Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus , 2015, Nature.

[68]  J. Chien,et al.  PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. , 2015, European journal of cancer.

[69]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[70]  R. Deberardinis,et al.  Metabolic pathways promoting cancer cell survival and growth , 2015, Nature Cell Biology.

[71]  Takeshi Tokuhisa,et al.  The role of autophagy during the early neonatal starvation period , 2004, Nature.

[72]  A. Mancuso,et al.  Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress. , 2013, Genes & development.

[73]  S. Akira,et al.  Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages , 2009, Nature Cell Biology.

[74]  E. White,et al.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.

[75]  P. Klenerman,et al.  Autophagy is a critical regulator of memory CD8+ T cell formation , 2014, eLife.

[76]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[77]  William A. Gahl,et al.  Cysteamine Suppresses Invasion, Metastasis and Prolongs Survival by Inhibiting Matrix Metalloproteinases in a Mouse Model of Human Pancreatic Cancer , 2012, PloS one.

[78]  J. Bonifacino,et al.  Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 γ–σ1 and AP-3 δ–σ3 hemicomplexes , 2003, The Journal of cell biology.

[79]  L. Galluzzi,et al.  Chloroquine and hydroxychloroquine for cancer therapy , 2014, Molecular & cellular oncology.

[80]  Christian M. Metallo,et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.

[81]  C. L. Chu,et al.  M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis , 2011, PloS one.

[82]  B. Turk Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.

[83]  Rugang Zhang,et al.  Nucleotide metabolism, oncogene-induced senescence and cancer. , 2015, Cancer letters.

[84]  J. Campisi,et al.  Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation , 2004, Journal of Cell Science.

[85]  S. Cohen,et al.  Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor , 1979, The Journal of cell biology.

[86]  M. Bisoffi,et al.  Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate‐specific antigen expression and secretion , 2013, International journal of cancer.

[87]  K. Ryan,et al.  Autophagy and cancer. , 2012, Cold Spring Harbor perspectives in biology.

[88]  Valerio Embrione,et al.  A Gene Network Regulating Lysosomal Biogenesis and Function , 2009, Science.

[89]  H. Algül,et al.  Risk Factors and Therapeutic Targets in Pancreatic Cancer , 2013, Front. Oncol..

[90]  M. Raff,et al.  Size Control: The Regulation of Cell Numbers in Animal Development , 1996, Cell.

[91]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[92]  D. Tuveson,et al.  The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1 , 2015, Cell.

[93]  Gordon B. Mills,et al.  Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.

[94]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[95]  I. Vlodavsky,et al.  The heparanase system and tumor metastasis: is heparanase the seed and soil? , 2011, Cancer and Metastasis Reviews.

[96]  A. Schulze,et al.  Linking glycogen and senescence in cancer cells. , 2012, Cell metabolism.

[97]  M. Kirby,et al.  Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. , 2009, Clinical science.

[98]  L. Walker,et al.  Confusing signals: Recent progress in CTLA-4 biology , 2015, Trends in immunology.

[99]  P. A. Pérez-Mancera,et al.  Inside and out: the activities of senescence in cancer , 2014, Nature Reviews Cancer.

[100]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[101]  Jon J Briggs,et al.  Cystatin E/M suppresses legumain activity and invasion of human melanoma , 2010, BMC Cancer.

[102]  D. Bar-Sagi,et al.  Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. , 1986, Science.

[103]  C. Pethiyagoda,et al.  Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells , 2004, Clinical & Experimental Metastasis.

[104]  S. Turner,et al.  Jailbreak: oncogene-induced senescence and its evasion. , 2011, Cellular signalling.

[105]  Peter Kraft,et al.  Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development , 2014, Nature Medicine.

[106]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[107]  M. Matsuda,et al.  Syndecan 4 Regulates FGFR1 Signaling in Endothelial Cells by Directing Macropinocytosis , 2012, Science Signaling.

[108]  H. Lien,et al.  Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity. , 2006, Lung cancer.

[109]  E. White,et al.  A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.

[110]  S. Ang,et al.  The role of secretory and endocytic pathways in the maintenance of cell polarity. , 2012, Essays in biochemistry.

[111]  D. Finkelstein,et al.  Regulated lysosomal exocytosis mediates cancer progression , 2015, Science Advances.

[112]  Toshihiko Kobayashi,et al.  How do cells optimize luminal environments of endosomes/lysosomes for efficient inflammatory responses? , 2013, Journal of biochemistry.

[113]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[114]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[115]  B. Henderson,et al.  IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[116]  M. Washington,et al.  Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. , 1995, Oncogene.

[117]  M. Hengartner Apoptosis Corralling the Corpses , 2001, Cell.

[118]  K. Okumura,et al.  Cathepsin K-mediated notch1 activation contributes to neovascularization in response to hypoxia , 2014, Nature Communications.

[119]  M. Montgomery,et al.  Dominant‐negative effect of truncated mannose 6‐phosphate/insulin‐like growth factor II receptor species in cancer , 2012, The FEBS journal.

[120]  E. Im,et al.  Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.

[121]  S. Manalis,et al.  Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells. , 2016, Developmental cell.

[122]  William J. Israelsen,et al.  Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. , 2014, Molecular cell.

[123]  J. Lippincott-Schwartz,et al.  Role of Grb2 in EGF-stimulated EGFR internalization. , 2002, Journal of cell science.

[124]  J. Taub,et al.  New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia. , 2014, Cellular signalling.

[125]  Peter D. Adams,et al.  Lysosome-mediated processing of chromatin in senescence , 2013, The Journal of cell biology.

[126]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[127]  Matthew G. Vander Heiden,et al.  Exploiting tumor metabolism: challenges for clinical translation , 2013 .

[128]  Seamus J. Martin,et al.  Autophagy in malignant transformation and cancer progression , 2015, The EMBO journal.

[129]  J. Falls,et al.  Imprinted M6p/Igf2 receptor is mutated in rat liver tumors , 1998, Oncogene.

[130]  I. Katona,et al.  Regulation of endoplasmic reticulum turnover by selective autophagy , 2015, Nature.

[131]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[132]  E. White,et al.  Role of Autophagy in Cancer Prevention , 2011, Cancer Prevention Research.

[133]  A. Kimmelman,et al.  The dynamic nature of autophagy in cancer. , 2011, Genes & development.

[134]  K. Anderson,et al.  Regulated nuclear import of Rel proteins in the Drosophila immune response , 1998, Nature.

[135]  D. Klionsky,et al.  The machinery of macroautophagy , 2013, Cell Research.

[136]  D. DiMaio,et al.  Senescence‐associated β‐galactosidase is lysosomal β‐galactosidase , 2006 .

[137]  A. Ballabio,et al.  Lysosome: regulator of lipid degradation pathways , 2014, Trends in cell biology.

[138]  Y. Assaraf,et al.  Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers , 2012, Cell Death and Disease.

[139]  Shengbing Huang,et al.  The Role of Autophagy in Cancer: Therapeutic Implications , 2011, Molecular Cancer Therapeutics.

[140]  L. Holsinger,et al.  Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. , 2010, Biochimie.

[141]  Liang Liu,et al.  Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells , 2014, Scientific Reports.

[142]  A. Brech,et al.  Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes. , 2003, The Biochemical journal.

[143]  A. Ullrich,et al.  The discovery of receptor tyrosine kinases: targets for cancer therapy , 2004, Nature Reviews Cancer.

[144]  Jae U. Jung,et al.  Autophagy genes as tumor suppressors. , 2010, Current opinion in cell biology.

[145]  Sophie Dahan,et al.  Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction. , 2016, Annual review of biochemistry.

[146]  A. Houghton,et al.  Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells , 2004, International journal of cancer.

[147]  J. Debnath,et al.  Autophagy and cancer metabolism. , 2014, Methods in enzymology.

[148]  Hongbin Ji,et al.  Regulation of EGFR nanocluster formation by ionic protein-lipid interaction , 2014, Cell Research.

[149]  Xiaonan Dong,et al.  Fanconi Anemia Proteins Function in Mitophagy and Immunity , 2016, Cell.

[150]  Chi Li,et al.  Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis , 2005, Cell.

[151]  Lewis A. Chodosh,et al.  Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis , 2007, Nature Cell Biology.

[152]  T. Irimura,et al.  Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. , 1984, The Journal of biological chemistry.

[153]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[154]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[155]  K. Ye,et al.  Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation. , 2014, The Journal of clinical investigation.

[156]  A. Malmström,et al.  TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated , 2011, Journal of Translational Medicine.

[157]  Z. Wang,et al.  PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection , 2016, Tumor Biology.

[158]  C. Johannessen,et al.  A negative feedback signaling network underlies oncogene-induced senescence. , 2006, Cancer cell.

[159]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[160]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[161]  Matthew P. Jacobson,et al.  Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.

[162]  D. Sabatini,et al.  Nutrient-sensing mechanisms and pathways , 2015, Nature.

[163]  S. Ryter,et al.  Autophagy in Inflammatory Diseases , 2011, International journal of cell biology.

[164]  R. Amaravadi,et al.  Targeting the lysosome in cancer , 2016, Annals of the New York Academy of Sciences.

[165]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[166]  J. Garin,et al.  An Extended Proteome Map of the Lysosomal Membrane Reveals Novel Potential Transporters* , 2013, Molecular & Cellular Proteomics.

[167]  K. Macleod,et al.  Mitophagy and cancer , 2015, Cancer & Metabolism.

[168]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[169]  L. P. Van den Heuvel,et al.  Cysteamine: an old drug with new potential. , 2013, Drug discovery today.

[170]  C. Heldin,et al.  Suppressors of T-cell Receptor Signaling Sts-1 and Sts-2 Bind to Cbl and Inhibit Endocytosis of Receptor Tyrosine Kinases* , 2004, Journal of Biological Chemistry.

[171]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[172]  A. Ballabio,et al.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.

[173]  A. Amon,et al.  Aneuploidy triggers a TFEB-mediated lysosomal stress response , 2015, Autophagy.

[174]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[175]  M. Jäättelä,et al.  Lysosomal cell death at a glance , 2013, Journal of Cell Science.

[176]  M. Lyon,et al.  The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.

[177]  P. Hines A Tale of Two Stomata , 2011, Science Signaling.

[178]  D. Sabatini,et al.  Sestrin2 is a leucine sensor for the mTORC1 pathway , 2016, Science.

[179]  C. Gey,et al.  Metabolic changes during cellular senescence investigated by proton NMR-spectroscopy , 2013, Mechanisms of Ageing and Development.

[180]  G. Kroemer,et al.  Lysosomal membrane permeabilization in cell death , 2008, Oncogene.

[181]  D. Kurz,et al.  Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. , 2000, Journal of cell science.

[182]  H. Stein,et al.  Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.

[183]  G. Superti-Furga,et al.  SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1 , 2014, Nature.

[184]  M. Washington,et al.  M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity , 1995, Nature Genetics.

[185]  W. Razaq Bone Targeted Therapies for Bone Metastasis in Breast Cancer , 2013, Journal of clinical medicine.

[186]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[187]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[188]  Amy Y. M. Au,et al.  p53 status determines the role of autophagy in pancreatic tumour development , 2013, Nature.

[189]  E. White Role of autophagy in cancer , 2012 .

[190]  L. Chiarelli,et al.  Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase , 2012 .

[191]  K. Lidke,et al.  The spatiotemporal organization of ErbB receptors: insights from microscopy. , 2014, Cold Spring Harbor perspectives in biology.

[192]  T. Hsia,et al.  Novel quinolone CHM‐1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[193]  S. Sarkar,et al.  Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor. , 2012, Anticancer research.

[194]  E. White,et al.  Aneuploidy-induced cellular stresses limit autophagic degradation , 2015, Genes & development.

[195]  E. Mckenzie,et al.  Heparanase: a target for drug discovery in cancer and inflammation , 2007, British journal of pharmacology.

[196]  M. Corrotte,et al.  Damage control: cellular mechanisms of plasma membrane repair. , 2014, Trends in cell biology.

[197]  S. Mitani,et al.  Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion , 2016, The Journal of cell biology.

[198]  T. Jacks,et al.  Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. , 2013, Genes & development.

[199]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[200]  U. Felbor,et al.  Sensitization to the Lysosomal Cell Death Pathway upon Immortalization and Transformation , 2004, Cancer Research.

[201]  T. Gonda,et al.  PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models , 2011, British Journal of Cancer.

[202]  K. Hahn,et al.  Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling , 2010, The Journal of cell biology.

[203]  Yoshito Yamada,et al.  Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice , 2015, Clinical & Experimental Metastasis.

[204]  Nektarios Tavernarakis,et al.  A dual role of p53 in the control of autophagy , 2008, Autophagy.

[205]  B. Lindkvist,et al.  Cathepsin B Activates Human Trypsinogen 1 but Not Proelastase 2 or Procarboxypeptidase B , 2006, Pancreatology.

[206]  K. Ravichandran,et al.  Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. , 2013, Cold Spring Harbor perspectives in biology.

[207]  Guido Kroemer,et al.  Lysosomes and autophagy in cell death control , 2005, Nature Reviews Cancer.

[208]  G. Peters,et al.  Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance , 2011, Clinical Cancer Research.

[209]  J. Beaulieu,et al.  Loss of cathepsin L activity promotes claudin‐1 overexpression and intestinal neoplasia , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.